( en | de | ru )

 

Disambiguation of "Collins, James J."

Author of the publication

copydeleteadd this publication to your clipboard
Tracking, tuning, and terminating microbial physiology using synthetic riboregulators

, , , , and . Proceedings of the National Academy of Sciences, 107 (36): 15898--15903 (Sep 7, 2010)
DOI: 10.1073/pnas.1009747107

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

James Collins

Katherine James

Audrein James

Michael James

Ammini James-Mammoottil

 

Other publications of authors with the same name

Stochasticity in gene expression: from theories to phenotypes, , , and . Nature Reviews Genetics, 6 (6): 451--464 (May 10, 2005)Integrating biological redesign: where synthetic biology came from and where it needs to go., , , and . Cell, 157 (1): 151--161 (Mar 27, 2014)Tracking, tuning, and terminating microbial physiology using synthetic riboregulators, , , , and . Proceedings of the National Academy of Sciences, 107 (36): 15898--15903 (Sep 7, 2010)Synthetic biology platform technologies for antimicrobial applications., , and . Advanced drug delivery reviews, 105 (Pt A): 35--43 (Oct 1, 2016)Editorial overview: Antimicrobials: Grappling with the complexities of antibiotics and resistance, and . Current Opinion in Microbiology, (October 2014)Syntrophic exchange in synthetic microbial communities, , , and . Proc. Natl. Acad. Sci. U. S. A., (2014)Bacterial charity work leads to population-wide resistance., , , and . Nature, 467 (7311): 82--85 (Sep 2, 2010)Toehold switches: de-novo-designed regulators of gene expression., , , and . Cell, 159 (4): 925--939 (Nov 6, 2014)Discovery of a structural class of antibiotics with explainable deep learning., , , , , , , , , and 11 other author(s). Nat., 626 (7997): 177-185 (February 2024)Deep learning identifies synergistic drug combinations for treating COVID-19., , , , , , , and . Proc. Natl. Acad. Sci. USA, 118 (39): e2105070118 (2021)